The latest biotech news

News and Trends 9 Jul 2020

€18M to Fund First-in-Class Systemic Sclerosis Drug

One of the largest biotech placements in the Nordic countries this year will accelerate the development of a first-in-class drug for chronic inflammation conditions such as systemic sclerosis that lacks the cardiovascular risks of current medications such as aspirin. Swedish biotech Gesynta Pharma raised €18.2M (SEK 190M) in a placement supported by returning investor Industrifonden […]

July 9, 2020 - 2 minutesmins - By Victor Kotsev

News and Trends 8 Jul 2020

Osivax Raises €32M to Develop Universal Coronavirus and Influenza Vaccines

Osivax, a Lyon-based biotechnology company, secured €17.5M from the European Innovation Council and €15.1M from Bpifrance. The funding will be used to develop vaccines that protect from all current – and even future – flu and coronavirus outbreaks. Most current vaccines have a specific target protein they work against. They train the immune system to […]

July 8, 2020 - 3 minutesmins - By Kostas Vavitsas

News and Trends 8 Jul 2020

Remdesivir Becomes the First Covid-19 Treatment Approved in Europe

Remdesivir has received a one-year conditional marketing authorization from the European Commission due to the urgency of the Covid-19 pandemic, which has infected at least 2.5 million people in Europe, and killed more than 500,000. The intravenous drug, manufactured by US pharma company Gilead Sciences, is intended for adults and children over the age of […]

July 8, 2020 - 3 minutesmins - By Victor Kotsev

News and Trends 7 Jul 2020

UK Launches Clinical Trial Platform to Speed up Covid-19 Drug Development

Researchers in the UK have set up a drug testing platform to bridge the gap between preclinical testing and large-scale trials for drugs being tested to treat Covid-19. The AGILE platform is a collaboration between the University of Liverpool, the Liverpool School of Tropical Medicine, and the Southampton Clinical Trials Unit that aims to speed […]

July 7, 2020 - 3 minutesmins - By Helen Albert

News and Trends 7 Jul 2020

Hansa Biopharma Gets up to €350M to Make Gene Therapy Work in Resistant Patients

Hansa Biopharma has granted an exclusive license to Sarepta Therapeutics for developing and promoting a pretreatment aimed to make a gene therapy to treat muscular dystrophy available to people that are naturally resistant to the treatment. Gene therapy can be used to treat genetic conditions by delivering a healthy copy of the faulty gene using […]

July 7, 2020 - 2 minutesmins - By Antara Mazumdar

News and Trends 7 Jul 2020

Dutch-Swiss Team to Fight Milk Fraud with Onsite DNA Testing

Microfluidics company DigiBio and food security specialist SwissDeCode have joined forces to automate onsite milk testing and track down fraudulent adulterants such as vegetable ingredients or milk from different species. Milk is the second most likely food at risk of adulteration after olive oil. This fraudulent practice can mislead consumers at best, and cause major […]

July 7, 2020 - 3 minutesmins - By Manuela Callari

News and Trends 3 Jul 2020

CRISPR Therapeutics Announces Huge €400M Public Fundraise

The Swiss firm CRISPR Therapeutics has priced a public offering on the Nasdaq Global Market at around €400M, which it will use to develop therapies based on the gene editing tool CRISPR/Cas9 for genetic disorders and cancer. This fundraise is the second-highest global share offering from a European biotech so far this year after the […]

July 3, 2020 - 2 minutesmins - By Laura Cowen

News and Trends 3 Jul 2020

Pfizer-BioNTech Covid-19 Vaccine Shows Phase I Promise

A vaccine made out of messenger RNA (mRNA), developed by the US pharmaceutical giant Pfizer and its German partner BioNTech, has produced antibodies against the Covid-19 pathogen in healthy volunteers. The results come from an interim analysis of an ongoing phase I clinical trial in 45 participants. So far, all test subjects who received two […]

July 3, 2020 - 3 minutesmins - By Victor Kotsev

News and Trends 2 Jul 2020

Freeline Closes €106M Series C to Progress Hemophilia Gene Therapy

UK biotech Freeline Therapeutics has extended its Series C round to take its gene therapy for hemophilia B to a pivotal trial, while hinting at the possibility of an IPO in the US later this year. This final closing adds an additional €70M to a €36M Series C investment by London-based VC Syncona in December […]

July 2, 2020 - 3 minutesmins - By Helen Albert

sonoran desert toad psychedelic beckley psytech

News and Trends 1 Jul 2020

UK Startup Bags €3M to Develop Psychedelic Medicines for Mental Health

A €3.3M (£3M) Series A round raised by the Oxford-based biomedicine company Beckley Psytech will allow the company to study the use of a psychedelic compound for the treatment of mental health disorders and neuropsychiatric disease. The investors include the UK VC firms Mediqventures and Jamjar Investments, which was set up by Richard Reed, co-founder […]

July 1, 2020 - 3 minutesmins - By Kostas Vavitsas

News and Trends 1 Jul 2020

Swiss Regenerative Medicine Biotech Closes €19M Series B

The regenerative medicine startup Cutiss has raised €18.8M (CHF 20M) to commercialize its personalized skin graft treatment for burn patients in Switzerland and the European Union around 2022. This is the final closing of a Series B round announced earlier this month. The lead investor in the oversubscribed round was the Swiss firm Gisev Family […]

July 1, 2020 - 3 minutesmins - By David Wilson

News and Trends 30 Jun 2020

Kymab Wins UK Supreme Court Antibody Battle Against Regeneron

The UK Supreme Court has supported an appeal by British biotech Kymab to revoke antibody drug patents held by US giant Regeneron, a decision that could make it harder for big patent holders to clamp down on small innovators in the biotech industry. Kymab and Regeneron have been battling it out in the UK since […]

June 30, 2020 - 4 minutesmins - By Anita Chakraverty

Knowledge hub

Categories

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Approaches

Therapeutic areas

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

News and Trends

€18M to Fund First-in-Class Systemic Sclerosis Drug

Osivax Raises €32M to Develop Universal Coronavirus and Influenza Vaccines

Remdesivir Becomes the First Covid-19 Treatment Approved in Europe

UK Launches Clinical Trial Platform to Speed up Covid-19 Drug Development

Hansa Biopharma Gets up to €350M to Make Gene Therapy Work in Resistant Patients

Dutch-Swiss Team to Fight Milk Fraud with Onsite DNA Testing

CRISPR Therapeutics Announces Huge €400M Public Fundraise

Pfizer-BioNTech Covid-19 Vaccine Shows Phase I Promise

Freeline Closes €106M Series C to Progress Hemophilia Gene Therapy

UK Startup Bags €3M to Develop Psychedelic Medicines for Mental Health

Swiss Regenerative Medicine Biotech Closes €19M Series B

Kymab Wins UK Supreme Court Antibody Battle Against Regeneron

Subscribe to our newsletter to get the latest biotech news!

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!